Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlpha Growth Regulatory News (ALGW)

Share Price Information for Alpha Growth (ALGW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.75
Bid: 1.60
Ask: 1.90
Change: -0.05 (-2.78%)
Spread: 0.30 (18.75%)
Open: 1.85
High: 1.80
Low: 1.75
Prev. Close: 1.80
ALGW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of Colva

1 Mar 2019 07:00

RNS Number : 5169R
Alpha Growth PLC
01 March 2019
 

1 March 2019

Alpha Growth plc

("Alpha", or the "Company")

 

Acquisition of Colva

 

Alpha Growth plc (LSE: ALGW), the financial services specialist in the growing Senior Life Settlement ("SLS") asset class, is pleased to announce the acquisition of Colva Insurance Services Corp. ("Colva").

The Company has signed an agreement for the acquisition of the entire ordinary share capital of Colva. Colva is a specialist actuarial service provider to the SLS industry and has a number of key clients, primarily based in the US.

The major shareholder of Colva is Rajiv Rebello, who founded Colva in order to use his first hand actuarial and life insurance expertise to minimize premium payments and maximize returns for life insurance and life settlement investors. Rajiv is a Fellow of the Society of Actuaries (FSA) and prior to Colva worked on AIG's 4,000+ policy life settlement portfolio with $18 billion in face. Prior to AIG, Rajiv worked at New York Life helping to price, design and create illustration software for their Universal Life and Variable Universal Life products. While at New York Life, Rajiv was also involved in analyzing mortality and lapse data experience and the creation of a new mortality table for New York Life. Colva is incorporated in California, USA, company number 3404971.

Alpha will acquire the entire share capital of Colva for a total consideration of £77,727 which shall be settled through the issue of 3,985,985 new ordinary shares of 0.1 pence each in the Company at an issue price of 1.95p per share, being the closing price of Alpha's shares on the day heads of terms were agreed. The shares will be issued and admitted for trading on the one year anniversary of the acquisition, subject to Rajiv continuing to be commercially engaged with Alpha on the issue date.

Further announcements will be made in due course.

 

Gobind Sahney, Chairman commented:

"The acquisition of Colva includes the addition of Rajiv who will become our Chief Actuary and Director of Investment Analytics. Rajiv is a terrific addition to the team and expands our in-house abilities to provide clients with superior advise and guidance on longevity assets. We welcome Rajiv and the clients that Colva works with to the Alpha team."

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

For more information, please visit www.algwplc.com or contact the following:

 

Alpha Growth plc

+44 (0) 20 3959 8600

Gobind Sahney, Executive Chairman

info@algwplc.com

 

 

Vox Markets (Digital IR)

+44 (0) 203 865 0130

Abraham Darwyne

content@voxmarkets.co.uk

 

 

Novum Securities Limited (Corporate Broker)

+44 (0) 207 399 9400

Colin Rowbury

crowbury@novumsecurities.com

 

About Alpha Growth plcSpecialist in Longevity AssetsAlpha Growth plc is a financial advisory business providing specialist consultancy, advisory, and supplementary services to institutional and qualified investors globally in the multi-billion dollar market of longevity assets. Building on its well-established network, Alpha Growth has a unique position in the longevity asset services and investment business, as a listed entity with global reach. The Company's strategy is to expand its advisory and business services via acquisitions and joint ventures in the UK and the US to attain commercial scale and provide wholistic solutions to alternative institutional investors who are in need of specialised skills and unique access to deploy their financial resource in longevity assets.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ACQDBGDDDGDBGCI
Date   Source Headline
24th Mar 20222:00 pmRNSPrice Monitoring Extension
24th Mar 20227:00 amRNSAcquisition and Insurance Business Update
7th Mar 20224:41 pmRNSSecond Price Monitoring Extn
7th Mar 20224:35 pmRNSPrice Monitoring Extension
7th Mar 20222:05 pmRNSSecond Price Monitoring Extn
7th Mar 20222:00 pmRNSPrice Monitoring Extension
7th Mar 202211:06 amRNSSecond Price Monitoring Extn
7th Mar 202211:00 amRNSPrice Monitoring Extension
28th Feb 20227:00 amRNSBusiness Update - 2022 Focus and the 2B Plan
21st Feb 20227:00 amRNSAppointment of new Strategic Advisor
2nd Feb 20227:00 amRNSBlackOak Alpha Growth Fund 2021 Year End Results
20th Dec 20217:00 amRNSPublication of a Prospectus
17th Dec 20217:00 amRNSChange of Adviser
13th Dec 20216:14 pmRNSHolding(s) in Company
29th Oct 202112:00 pmRNSInterim Results for Extension in Accounting Period
2nd Sep 20214:41 pmRNSSecond Price Monitoring Extn
2nd Sep 20214:35 pmRNSPrice Monitoring Extension
12th Aug 20214:40 pmRNSSecond Price Monitoring Extn
12th Aug 20214:35 pmRNSPrice Monitoring Extension
19th Jul 20214:40 pmRNSSecond Price Monitoring Extn
19th Jul 20214:35 pmRNSPrice Monitoring Extension
19th Jul 20217:00 amRNSTrading Update Q2 2021
6th Jul 20218:00 amRNSChange of Year End
16th Jun 20217:00 amRNSClarification of News
15th Jun 202111:05 amRNSSecond Price Monitoring Extn
15th Jun 202111:00 amRNSPrice Monitoring Extension
15th Jun 20219:05 amRNSSecond Price Monitoring Extn
15th Jun 20219:00 amRNSPrice Monitoring Extension
7th Jun 20217:00 amRNSHolding(s) in Company
7th Jun 20217:00 amRNSWarrants Exercise and Admission Date
2nd Jun 20217:00 amRNSHolding(s) in Company
28th May 20214:00 pmRNSInterim Results
19th May 20217:00 amRNSExercise of Warrants and Total Voting Rights
14th May 20217:00 amRNSHolding(s) in Company
13th May 20214:41 pmRNSSecond Price Monitoring Extn
13th May 20214:35 pmRNSPrice Monitoring Extension
5th May 20214:42 pmRNSSecond Price Monitoring Extn
5th May 20214:36 pmRNSPrice Monitoring Extension
27th Apr 20214:41 pmRNSSecond Price Monitoring Extn
27th Apr 20214:35 pmRNSPrice Monitoring Extension
27th Apr 20212:05 pmRNSSecond Price Monitoring Extn
27th Apr 20212:00 pmRNSPrice Monitoring Extension
23rd Apr 20214:41 pmRNSSecond Price Monitoring Extn
23rd Apr 20214:35 pmRNSPrice Monitoring Extension
20th Apr 20214:40 pmRNSSecond Price Monitoring Extn
20th Apr 20214:36 pmRNSPrice Monitoring Extension
9th Apr 20219:05 amRNSSecond Price Monitoring Extn
9th Apr 20219:00 amRNSPrice Monitoring Extension
9th Apr 20217:00 amRNSTrading Update Q1 2021
23rd Mar 20214:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.